Related Experiment Video
Updated: Jun 23, 2025

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
De-Escalation of Therapy for Low-Grade Papillary Bladder Tumors With Preserved Long-Term Oncologic Outcomes
1Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Urology Practice
|June 24, 2024
Abstract
No abstract available in PubMed .

